Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004490924 | SCV004990678 | uncertain significance | not specified | 2024-03-01 | criteria provided, single submitter | clinical testing | The c.1676A>G (p.Y559C) alteration is located in exon 3 (coding exon 3) of the NPC1L1 gene. This alteration results from a A to G substitution at nucleotide position 1676, causing the tyrosine (Y) at amino acid position 559 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |